神经药理学报››2020,Vol. 10››Issue (3): 54-64.DOI:10.3969/j.issn.2095-1396.2020.03.010
• 综述 •上一篇
熊梦瑶,贾英丽,杨宝学
出版日期:
2020-06-26发布日期:
2021-05-14通讯作者:
杨宝学,教授;研究方向:肾脏药理学;E-mail: baoxue@bjmu.edu.cn作者简介:
熊梦瑶,博士研究生;研究方向:肾脏药理学;E-mail: mengyaoX1995@163.com基金资助:
XIONG Meng-yao,JIA Ying-li,YANG Bao-xue
Online:
2020-06-26Published:
2021-05-14Contact:
杨宝学,教授;研究方向:肾脏药理学;E-mail: baoxue@bjmu.edu.cnAbout author:
熊梦瑶,博士研究生;研究方向:肾脏药理学;E-mail: mengyaoX1995@163.comSupported by:
摘要:
中图分类号:
熊梦瑶, 贾英丽, 杨宝学. 前列腺素受体4 与肾脏疾病相关性研究进展[J]. 神经药理学报, 2020, 10(3): 54-64.
XIONG Meng-yao, JIA Ying-li, YANG Bao-xue. Relationship between Prostaglandin Receptor EP4 and Renal Diseases[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 54-64.
1. Wang J, M, Liu, X, Zhang,et al.Physiological and pathophysiological implications of PGE and the PGE synthases in the kidney[J].Prostaglandins & other lipid mediators,2018,134:1-6. 2. James V Michael, Adelina Gavrila, Ajay P Nayak,et al.Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle[J].FASEB J: Official Publication of the Federation of American Societies for Experimental Biology, 2019, 33(4): 4780-4789. 3. Yukihiko Sugimoto, Shuh Narumiya.Prostaglandin E receptors[J]. J Biol Chem, 2007, 282(16): 11613-11617. 4. Jean B Regard, Isaac T Sato, Shaun R Coughlin.Anatomical profiling of G protein-coupled receptor expression[J].Cell, 2008, 135(3): 561-71. 5. Arantzazu Alfranca, Miguel A Iniguez, Manuel Fresno,et al.Prostanoid signal transduction and gene expression in the endothelium: role in cardiovascular diseases[J].Cardiovasc Res, 2006, 70(3): 446-56. 6. Utako Yokoyama, Kousaku Iwatsubo, Masanarl Umemura,et al.The prostanoid EP4 receptor and its signaling pathway[J].Pharmacological Reviews, 2013, 65(3): 1010-52. 7. Brian K Kobilka.G protein coupled receptor structure and activation[J].Biochim Biophys Acta, 2007, 1768(4): 794-807. 8. Shinsuke Mizoguchi, Amanda S Wolf-Johnson, Jian-shu Ni,et al.The role of prostaglandin and E series prostaglandin receptor type 4 receptors in the development of bladder overactivity in a rat model of chemically induced prostatic inflammation[J].BJU International, 2019, 124(5): 883-891. 9. Chandramohan Natarajan, Aaron N Hata, Heldi E Hamm,et al.Extracellular loop II modulates GTP sensitivity of the prostaglandin EP3 receptor[J].Molecular Pharmacology, 2013, 83(1): 206-216. 10. Yosuke Toyoda, Kazushi Morimoto, Ryoji Suno,et al.Ligand binding to human prostaglandin E receptor EP at the lipid-bilayer interface[J].Nature Chemical Biology, 2019, 15(1): 18-26. 11. Lamine Aoudjit, Anna Potapov, Tomoko Takano.Prostaglandin E2 promotes cell survival of glomerular epithelial cells via the EP4 receptor[J].Am J Physiol Renal Physiol, 2006, 290(6): F1534-42. 12. Emi Yamamoto, Takeshi Izawa, Mitsuru Kuwamura,et al.Immunohistochemical expressions of main PGE(2) biosynthesis-related enzymes and PGE(2) receptor in rat nephrogenesis[J].J Toxicologic Pathology, 2011, 24(4): 257-61. 13. Boye L Jensen, Jane Stubbe, Pernille Hansen,et al.Localization of prostaglandin E(2) EP2 and EP4 receptors in the rat kidney[J].American J Physiology Renal Physiology, 2001, 280(6): F1001-F1009. 14. Morath R, Thomas Klein, H W Seyberth,et al.Immunolocalization of the four prostaglandin E2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney[J].J the American Society of Nephrology : JASN, 1999, 10(9): 1851-60. 15. Tessa A Castleberry, Bi-hong Lu, Steven L Smock,et al.Molecular cloning and functional characterization of the canine prostaglandin E2 receptor EP4 subtype[J].Prostaglandins & Other Lipid Mediators, 2001, 65(4): 167-187. 16. Ren Yi-lin, Martin A D'Ambrosio, Jeffrey L Garvin,et al.Prostaglandin E2 mediates connecting tubule glomerular feedback[J].Hypertension (Dallas, Tex: 1979), 2013, 62(6): 1123-1128. 17. Nitta M, Ichiro Hirata, K Toshina,et al.Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist, ONO-AE1-329[J].Scandinavian J Immunology, 2002, 56(1): 66-75. 18. Chabha Benyahia, Ingrid Gomez, L Kanyinda,et al.PGE(2) receptor (EP(4)) agonists: potent dilators of human bronchi and future asthma therapy? [J].Pulmonary Pharmacology & Therapeutics, 2012, 25(1): 115-118. 19. Nabll Foudi, Kotelevets L, Louedec L,et al.Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype[J].Br J Pharmacol, 2008, 154(8): 1631-1639. 20. Konya V, Üllen A, Kampitsch N,et al. Endothelial E-type prostanoid 4 receptors promote barrier function and inhibit neutrophil trafficking [J]. The J Allergy and Clinical Immunology, 2013, 131(2): 532-40.e1-2. 21. Petra Luschnig-Schratl, Eva M Sturm, Viktoria Konya,et al.EP4 receptor stimulation down-regulates human eosinophil function[J].Cellular and MolecularLife Sciences : CMLS, 2011, 68(21): 3573-3587. 22. Sonia Philipose, Viktoria Konya, Ivana Sreckovic,et al.The prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formation[J].Arteriosclerosis, Thrombosis, and Vascular Biology, 2010, 30(12): 2416-2423. 23. Vukicevic S, Simic P, Borovecki F,et al.Role of EP2 and EP4 receptor-selective agonists of prostaglandin E(2) in acute and chronic kidney failure[J].Kidney International, 2006, 70(6): 1099-1106. 24. Liu Yu, Madhumitha Rajagopal, Kim Lee,et al.Prostaglandin E(2) mediates proliferation and chloride secretion in ADPKD cystic renal epithelia[J].American J Physiology Renal Physiology, 2012, 303(10): F1425- F1434. 25. Martin Leduc, Billy Breton, Celine Galés,et al.Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands[J].The J Pharmacology and Experimental Therapeutics, 2009, 331(1): 297-307. 26. Hiromichi Fujino, John W Regan.EP(4) prostanoid receptor coupling to a pertussis toxin-sensitive inhibitory G protein[J].Molecular Pharmacology, 2006, 69(1): 5. 27. Madhu B Anand-Srivastava. Modulation of Gi proteins in hypertension: role of angiotensin II and oxidative stress [J].Curr Cardiol Rev, 2010, 6(4): 298-308. 28. Hiromichi Fujino, Kimberly A West, John W ReganPhosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2[J].The J Biological Chemistry, 2002, 277(4): 2614-2619. 29. Fujino Hiromichi, Xu Wei, John W Regan.Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases[J].The J Biological Chemistry, 2003, 278(14): 12151-12156. 30. Peng Xiao-jie, Li Jian-zhong, Tan si-wei,et al.COX-1/PGE/EP4 alleviates mucosal injury by upregulating β-arr1-mediated Akt signaling in colitis[J].Scientific Reports, 2017, 7(1): 1055. 31. Jonathan Constance, Alfred Balch, Chris Stockmann,et al.A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates[J].Archives of Disease in Childhood. Fetal and Neonatal Edition, 2016, 101(3): F236-43. 32. Constance J E, D Reith, R M Ward,et al.Risk of nonsteroidal anti-inflammatory drug-associated renal dysfunction among neonates diagnosed with patent ductus arteriosus and treated with gentamicin[J]. J Perinatology : Official J the California Perinatal Association, 2017, 37(10): 1093-1102. 33. Stefanie Frölich, Anke Olliges, Nikias Kern,et al.Temporal expression of the PGE2 synthetic system in the kidney is associated with the time frame of renal developmental vulnerability to cyclooxygenase-2 inhibition[J].American J Physiology. Renal Physiology, 2012, 303(2): F209-19. 34. Lamine Aoudjit, Anna Potapov, Tomoko Takano.Prostaglandin E2 promotes cell survival of glomerular epithelial cells via the EP4 receptor[J].American J Physiology Renal physiology, 2006, 290(6): F1534- F1542. 35. Maria Augusta Gaspar.Renovascular hypertension: The current approach[J].Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2019, 38(12): 869-871. 36. Silva B R, L Pernomian, Tiago Dai-Cin De Paula,et al.Endothelial nitric oxide synthase and cyclooxygenase are activated by hydrogen peroxide in renal hypertensive rat aorta[J].European J Pharmacology, 2017, 814: 87-94. 37. Carie S Facemire, Robert Griffiths, Laurent P Audoly,et al.The impact of microsomal prostaglandin e synthase 1 on blood pressure is determined by genetic background[J].Hypertension (Dallas, Tex: 1979), 2010, 55(2): 531-538. 38. Zhang Dong-juan, Chen Li-hong, Zhang Ya-hua,et al.Enhanced pressor response to acute Ang II infusion in mice lacking membrane-associated prostaglandin E2 synthase-1[J].Acta Pharmacologica Sinica, 2010, 31(10): 1284-1292. 39. Chen Li-hong, Miao Yi-fei, Zhang Ya-hua,et al.Inactivation of the E-prostanoid 3 receptor attenuates the angiotensin II pressor response via decreasing arterial contractility[J].Arteriosclerosis, Thrombosis, and Vascular Biology, 2012, 32(12): 3024-3032. 40. Liu Bin, Wu Xiang-zhong, Zeng Ru-hui,et al.Prostaglandin E sequentially activates E-prostanoid receptor-3 and thromboxane prostanoid receptor to evoke contraction and increase in resistance of the mouse renal vasculature[J].FASEB J : official publication of the Federation of American Societies for Experimental Biology, 2020, 34(2): 2568-2578. 41. Laurent P Audoly, Stephen L Tilley, Jennifer Goulet,et al.Identification of specific EP receptors responsible for the hemodynamic effects of PGE2[J].The American J Physiology, 1999, 277(3): H924-30. 42. Hao C M, Breyer M D.Physiologic and pathophysiologic roles of lipid mediators in the kidney[J].Kidney International, 2007, 71(11): 1105-1115. 43. Frank Schweda, Jurgen Klar, Shuh Narumiya,et al.Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys[J].American J Physiology. Renal Physiology, 2004, 287(3): F427-F433. 44. Ulla G Friis, Jane Stubbe, Torhen R Uhrenholt,et al.Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells[J].Am J Physiol Renal Physiol, 2005, 289(5): F989-97. 45. Shigeo Negi, Daisuke Koreeda, Sou Kobayashi,et al.Acute kidney injury: Epidemiology, outcomes, complications, and therapeutic strategies[J].Seminars in Dialysis, 2018, 31(5): 519-527. 46. Stephanie F Smith, Sarah A Hosgood, Michael L Nicholson.Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells[J].Kidney International, 2019, 95(1): 50-56. 47. Maryam Malek, Mehdi Nematbakhsh.Renal ischemia/reperfusion injury; from pathophysiology to treatment[J].J Renal Injury Prevention, 2015, 4(2): 20-27. 48. Nur Arfian, Santosa Budiharjo, Dian Prasetyo Wibisono,et al.Vitamin D ameliorates kidney ischemia reperfusion injury via reduction of inflammation and myofibroblast expansion[J].The Kobe J Medical Sciences, 2020, 65(4): E138-E143. 49. Li Feng, Edward Suarez Moreira Bahnson, Jennifer Wilder,et al.Oral high dose vitamin B12 decreases renal superoxide and post-ischemia/reperfusion injury in mice[J].Redox Biology, 2020, 32: 101504. 50. Jeremiah Ogbadu, Gaaminepreet Singh, Kirti Gupta,et al.Ageing reduces angiotensin II type 1 receptor antagonism mediated pre-conditioning effects in ischemic kidneys by inducing oxidative and inflammatory stress[J].Experimental Gerontology, 2020, 135(1): 110892. 51. Rinaldo Bellomo, John A Kellum, Claudio Ronco.Acute kidney injury[J].BMJ Clinical Evidence, 2011, 380(9843): 756-766. 52. Klaus Höcherl, Christoph Schmidt, Michael Bucher.COX-2 inhibition attenuates endotoxin-induced downregulation of organic anion transporters in the rat renal cortex[J].Kidney international,2009,75(4):373-80. 53. Ding Chen-guang, Han Feng, Heli Xiang,et al.Role of prostaglandin E2 receptor 4 in the modulation of apoptosis and mitophagy during ischemia/reperfusion injury in the kidney[J].Mol Med Rep, 2019, 20(4): 3337-3346. 54. Christina Preising, Reinhard Schneider, Michael Bucher,et al.Regulation of expression of renal organic anion transporters OAT1 and OAT3 in a model of ischemia/reperfusion injury[J].Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2015, 37(1): 1-13. 55. Deng Cong, Chen Shan-shan, Li Xiong-feng,et al.Role of the PGE2 receptor in ischemia-reperfusion injury of the rat retina[J].Molecular Vision, 2020, 26: 36-47. 56. Zhu Li-yuan, Xu Chuan-sheng, Huo Xing-yu,et al.The cyclooxygenase-1/mPGES-1/endothelial prostaglandin EP4 receptor pathway constrains myocardial ischemia-reperfusion injury[J].Nature Communications, 2019, 10(1): 1888. 57. Cai Lin-lin, Xu Hai-tao, Wang Qi-long,et al.EP4 activation ameliorates liver ischemia/reperfusion injury via ERK1/2‑GSK3β‑dependent MPTP inhibition[J].International J Molecular Medicine, 2020, 45(6):1825-1837. 58. Christoph Sauvant, R Schneider, Hildegard Holzinger,et al.Indomethacin corrects alterations associated with ischemia/reperfusion in an in vitro proximal tubular model[J].American J Nephrology, 2010, 32(1): 57-65. 59. Hong Yu-Ah, Keum-Jin Yang, So-Young Jung,et al.Paricalcitol attenuates lipopolysaccharide-induced inflammation and apoptosis in proximal tubular cells through the prostaglandin E receptor EP4[J].Kidney Research and Clinical Practice, 2017, 36(2): 145-158. 60. Yu Ah Hong, Keum-Jin Yang, So Young Jung,et al.Paricalcitol pretreatment attenuates renal ischemia-reperfusion injury via prostaglandin E receptor EP4 pathway[J].Oxidative Medicine and Cellular Longevity, 2017, 2017(3):1-17. 61. Robert W Schrier, Wang Wei.Acute renal failure and sepsis[J].New England J Medicine, 2004, 351(2): 159-169. 62. Makita N, Manaka K, Sato J,et al. V2 vasopressin receptor mutations [J]. Vitamins and Hormones, 2020, 113: 79-99. 63. Daniel G Bichet.Vasopressin receptor mutations in nephrogenic diabetes insipidus[J]. Semin Nephrol, 2008, 28(3): 245-51. 64. Nielsen S, Tae-Hwan Kwon, Jorgen Frøkiaer,et al.Regulation and dysregulation of aquaporins in water balance disorders[J].J Internal Medicine, 2007, 261(1): 53-64. 65. Tae-Hwan Kwon, Henrik Hager, Lene Nejsum,et al.Physiology and pathophysiology of renal aquaporins[J].Seminars in Nephrology, 2001, 21(3): 231-238. 66. Daniel G Bichet.Nephrogenic diabetes insipidus[J].Current Opinion in Pediatrics, 2017, 29(2): 199-205. 67. Li Jian-hua, Chou Chung-lin, Li Bo,et al.A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus[J].The J Clinical Investigation, 2009, 119(10): 3115-3126. 68. Jeff M Sands, Harold E Layton.Advances in understanding the urine-concentrating mechanism[J].Annu Rev Physiol, 2014, 76: 387-409. 69. Tae-Hwan Kwon, Jørgen Frøkiær, Søren Nielsen.Regulation of aquaporin-2 in the kidney: A molecular mechanism of body-water homeostasis[J].Kidney Research and Clinical Practice, 2013, 32(3): 96-102. 70. Hanne B Moeller, Jeppe Praetorius, Michael R Rützler,et al.Phosphorylation of aquaporin-2 regulates its endocytosis and protein-protein interactions[J].Proceedings of the National Academy of Sciences of the United States of America, 2010, 107(1): 424-429. 71. Emma Tina Bisgaard Olesen, Michael Rutzler, Hanne B Moeller,et al.Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus[J].Proc Natl Acad Sci USA, 2011, 108(31): 12949-12954. 72. Gao Min, Cao Rong, Du Sheng-nan,et al.Disruption of prostaglandin E2 receptor EP4 impairs urinary concentration via decreasing aquaporin 2 in renal collecting ducts[J].Proceedings of the National Academy of Sciences of the United States of America, 2015, 112(27): 8397-8402. 73. Karthrin Eller, Tobias Weber, Monika Pruenster,et al.CCR7 deficiency exacerbates injury in acute nephritis due to aberrant localization of regulatory T cells[J].Journal of the American Society of Nephrology : JASN, 2010, 21(1): 42-52. 74. Dominik Wolf, Kathrin Hochegger, Anna M Wolf,et al.CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice[J].J the American Society of Nephrology : JASN, 2005, 16(5): 1360-1370. 75. Chadban S J, Atkins R C.Glomerulonephritis[J].Lancet (London, England), 2005, 365(9473): 1797-1806. 76. Tadashi Nagamatsu, Hirohito Imai, Michiyo Yokoi,et al.Protective effect of prostaglandin EP4-receptor agonist on anti-glomerular basement membrane antibody-associated nephritis[J].J Pharmacological Sciences, 2006, 102(2): 182-188. 77. Riyaz Mohamed, Calpurnla Jayakumar, Ganesan Ramesh.Chronic administration of EP4-selective agonist exacerbates albuminuria and fibrosis of the kidney in streptozotocin-induced diabetic mice through IL-6[J]. Laboratory Investigation: A J Technical Methods and Pathology, 2013, 93(8): 933-945. 78. Kazuhiro Furuhashi, Naotake Tsuboi, Asuka Shimizu,et al.Serum-starved adipose-derived stromal cells ameliorate crescentic GN by promoting immunoregulatory macrophages[J].J the American Society of Nephrology : JASN, 2013, 24(4): 587-603. 79. Ida Aringer, Katharina Artinger, Alexander H Kirsch,et al.Blockade of prostaglandin E receptor 4 ameliorates nephrotoxic serum nephritis[J].American J Physiology. Renal Physiology, 2018, 315(6): F1869-F1880. 80. Lin Yu-sheng, Mingli Hsieh, Yi-Ju Lee,et al.AH23848 accelerates inducible nitric oxide synthase degradation through attenuation of cAMP signaling in glomerular mesangial cells[J]. Nitric Oxide : Biology and Chemistry, 2008, 18(2): 93-104. 81. Jose M López-Novoa, Carlos Martínez-Salgado, Ana B Rodríguez-Peña,et al.Common pathophysiological mechanisms of chronic kidney disease: therapeutic perspectives[J]. Pharmacology & Therapeutics, 2010, 128(1): 61-81. 82. Duan Jia-yu, Duan Guang-Cai, Wang Chong-Jian,et al.Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central Chinese urban population: a cross-sectional survey[J].BMC Nephrology, 2020, 21(1): 115. 83. Hiddo Lambers Heerspink, Dick de Zeeuw.Novel drugs and intervention strategies for the treatment of chronic kidney disease[J]. British J Clinical Pharmacology, 2013, 76(4): 536-550. 84. Karina Thieme, Syamantak Majumder, Angela S Brijmohan,et al.EP4 inhibition attenuates the development of diabetic and non-diabetic experimental kidney disease[J].Scientific Reports, 2017, 7(1): 3442. 85. Francisco J Lopez-Hernandez, Jose M Lopez-Novoa.Role of TGF-beta in chronic kidney disease: an integration of tubular, glomerular and vascular effects[J]. Cell Tissue Res, 2012, 347(1): 141-154. 86. Yang Guang-Xia, Xu Yu-yin, Fan Ya-Ping,et al.A maladaptive role for EP4 receptors in mouse mesangial cells[J].PLoS One, 2014, 9(8): e104091. 87. Kazuhiko Mizukami, Hiroyuki Yoshida, Eisuke Nozawa,et al.Renoprotective effects of the novel prostaglandin EP4 receptor-selective antagonist ASP7657 in 5/6 nephrectomized chronic kidney disease rats[J].Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, 392(4): 451-459. 88. Hu Chun, Sun Lin, Xiao Ya-chun,et al.Insights into the mechanisms involved in the expression and regulation of extracellular matrix proteins in diabetic nephropathy[J].Current Medicinal Chemistry, 2015, 22(24): 2858-2870. 89. Peng Fang-Fang, Xiao Ze-Ling, Chen Hong-Min,et al.Parathyroid hormone inhibits TGF-β/Smad signaling and extracellular matrix proteins upregulation in rat mesangial cells[J].Biochemical and Biophysical Research Communications, 2016, 478(3): 1093-1098. 90. Convento M S, E Pessoa, M A Dalboni,et al.Pro-inflammatory and oxidative effects of noncrystalline uric acid in human mesangial cells: contribution to hyperuricemic glomerular damage[J].Urological Research, 2011, 39(1): 21-27. 91. Tadashi Nagamatsu, Toshiyuki Nagao, Jun-ichi Koseki,et al.Involvement of prostaglandin E2 in clearance of aggregated protein via protein kinase A in glomeruli[J]. Japanese J Pharmacology, 2001, 85(2): 139-145. 92. Cao Ying-Jie, Pan Tian-Yi, Chen Xiao-xian,et al.EP4 knockdown alleviates glomerulosclerosis through Smad and MAPK pathways in mesangial cells[J].Molecular Medicine Reports, 2018, 18(6): 5141-5150. 93. Erin M Stitt-Cavanagh, Wissam H Faour, Kaede Takami,et al.A maladaptive role for EP4 receptors in podocytes[J]. J the American Society of Nephrology: JASN, 2010, 21(10): 1678-1690. 94. Peter Harris, Sandro Rossetti.Molecular diagnostics for autosomal dominant polycystic kidney disease[J].Nature Reviews. Nephrology, 2010, 6(4): 197-206. 95. Hannah C Chapin, Michael Joseph Caplan.The cell biology of polycystic kidney disease[J].J Cell Biol, 2010, 191(4): 701-710. 96. Thomas Natoli, Tiffany C Gareski, William R Dackowski,et al.Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures[J].Am J Physiol Renal Physiol, 2008, 294(1): F73-83. 97. Gerard Elberg, Dorit Elberg, Teresa V Lewis,et al.EP2 receptor mediates PGE2-induced cystogenesis of human renal epithelial cells[J].American J Physiology. Renal Physiology, 2007, 293(5): F1622-F1632. 98. Malcolm R Ogborn, Evan Nitschmann, Nitschmann Bankovic-Calic,et al.Dietary conjugated linoleic acid reduces PGE2 release and interstitial injury in rat polycystic kidney disease[J].Kidney International, 2003, 64(4): 1214-1221. 99. Franck A Belibi, Gail Reif, Darren P Wallace,et al.Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells[J].Kidney International, 2004, 66(3): 964-973. 100. Anll Karihaloo, Christian Nickel, Lloyd G Cantley.Signals which build a tubule[J]. Nephron Experimental Nephrology, 2005, 100(1): e40-e45. |
[1] | 陈琳,杜力军, 赵玉男.糖皮质激素与海马结构可塑性[J]. 神经药理学报, 2011, 1(2): 58-64. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||